+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peripheral Drug Eluting Balloons Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 273 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5908998
Description Jump to:
The global market for peripheral drug eluting balloons (DEBs) is poised for remarkable growth, according to a recent study by the publisher. Over the past decade, the market has expanded at a commendable Compound Annual Growth Rate (CAGR) of 6%, reaching a valuation of US$880 million in 2024. Projections suggest a significant surge ahead, with an anticipated CAGR of 10.0% by the end of 2031, propelling the market to a valuation of US$1700 million.

Peripheral DEBs are critical medical devices used in interventional cardiology and other medical fields to address various cardiovascular conditions, particularly arterial blockages or stenosis. These devices combine mechanical balloon angioplasty with localized medication delivery, offering a comprehensive treatment approach.

Rising Aging Population and Increasing Prevalence of Vascular Diseases Driving Market Growth

One of the primary factors fueling the rapid expansion of the peripheral DEBs market is the global aging population and the consequent increase in vascular diseases. The geriatric demographic is particularly susceptible to vascular ailments, contributing to a heightened demand for peripheral vascular surgeries. Furthermore, with improved life expectancies and an expected rise in the global elderly population, opportunities for manufacturers are burgeoning. The World Health Organization estimates a staggering increase in the elderly population, from 900 million in 2015 to 2 billion by 2050.

Challenges Faced by Market Players

Despite the promising growth trajectory, market players encounter challenges, including high product costs and limited clinical evidence. The upfront expenses associated with DEBs, along with the need for robust long-term clinical data, pose obstacles to widespread adoption, especially in regions with constrained healthcare budgets or reimbursement constraints. Addressing these challenges is crucial for sustained market expansion and accessibility.

Country-wise Insights: United States, China, and Germany

In the United States, the market for peripheral DEBs is set to witness significant growth due to the rising prevalence of peripheral artery disease (PAD) and advancements in product development. Similarly, China presents lucrative opportunities driven by favorable government policies, healthcare reforms, and reimbursement support. Collaborations between local and international entities facilitate technology transfer and market expansion.

Germany, renowned for its advanced healthcare infrastructure, provides a conducive environment for the adoption of innovative medical technologies like DEBs. Awareness campaigns and education initiatives about peripheral artery disease are contributing to greater product acceptance and adoption in the country.

Category-wise Insights: Paclitaxel Drug Coating and Peripheral Arterial Disease Indication

Paclitaxel drug coating emerges as a significant driver of market demand, accounting for a substantial share in 2023. Its efficacy in inhibiting neointimal hyperplasia and reducing restenosis risk underscores its importance in peripheral DEBs. Additionally, the prevalence of peripheral arterial disease remains a dominating factor, with common risk factors contributing to its increasing incidence globally.

Competition Analysis

The market for peripheral drug eluting balloons boasts a competitive landscape, with global and local businesses vying for market share. Efforts to expand presence in emerging markets and maintain distributor connections underscore the competitive environment.

Key Segments of Peripheral Drug Eluting Balloons Industry Research

Drug Coating:

  • Paclitaxel Drug Coating
  • Sirolimus drug Coating
  • Others

Indication:

  • Peripheral Arterial Disease
  • Peripheral Aneurysms
  • In-Stent Restenosis
  • Others

Artery Type:

  • Carotid Arteries
  • Fem-Pop Arteries
  • Iliac Arteries
  • Infrapop Arteries

End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Peripheral Drug Eluting Balloon Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2018 - 2023
3.1. Global Peripheral Drug Eluting Balloon Market Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2018 - 2023
4.1. Global Average Price Analysis, by Drug Coating/ Material, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Single-use Bronchoscopes Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Peripheral Drug Eluting Balloon Market Outlook, 2018 - 2031
5.1. Global Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Paclitaxel Drug Coating
5.1.1.2. Sirolimus drug Coating
5.1.1.3. Others
5.2. Global Peripheral Drug Eluting Balloon Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Peripheral Arterial Disease
5.2.1.2. Peripheral Aneurysms
5.2.1.3. In-Stent Restenosis
5.2.1.4. Others
5.3. Global Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Carotid Arteries
5.3.1.2. Fem-Pop Arteries
5.3.1.3. Iliac Arteries
5.3.1.4. Infrapop Arteries
5.4. Global Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Ambulatory Surgical Centers/Outpatients
5.4.1.3. Cardiac Catheterization Labs
5.5. Global Peripheral Drug Eluting Balloon Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
6. North America Peripheral Drug Eluting Balloon Market Outlook, 2018 - 2031
6.1. North America Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Paclitaxel Drug Coating
6.1.1.2. Sirolimus drug Coating
6.1.1.3. Others
6.2. North America Peripheral Drug Eluting Balloon Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Peripheral Arterial Disease
6.2.1.2. Peripheral Aneurysms
6.2.1.3. In-Stent Restenosis
6.2.1.4. Others
6.3. North America Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Carotid Arteries
6.3.1.2. Fem-Pop Arteries
6.3.1.3. Iliac Arteries
6.3.1.4. Infrapop Arteries
6.4. North America Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Ambulatory Surgical Centers/Outpatients
6.4.1.3. Cardiac Catheterization Labs
6.5. North America Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. U.S. Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.5.1.2. U.S. Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.5.1.3. U.S. Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.5.1.4. U.S. Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.5.1.5. Canada Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.5.1.6. Canada Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.5.1.7. Canada Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.5.1.8. Canada Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Peripheral Drug Eluting Balloon Market Outlook, 2018 - 2031
7.1. Europe Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Paclitaxel Drug Coating
7.1.1.2. Sirolimus drug Coating
7.1.1.3. Others
7.2. Europe Peripheral Drug Eluting Balloon Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Peripheral Arterial Disease
7.2.1.2. Peripheral Aneurysms
7.2.1.3. In-Stent Restenosis
7.2.1.4. Others
7.3. Europe Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Carotid Arteries
7.3.1.2. Fem-Pop Arteries
7.3.1.3. Iliac Arteries
7.3.1.4. Infrapop Arteries
7.4. Europe Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.1. Hospitals
7.4.1.2. Ambulatory Surgical Centers/Outpatients
7.4.1.3. Cardiac Catheterization Labs
7.5. Europe Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Germany Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.2. Germany Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.3. Germany Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.4. Germany Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.5. U.K. Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.6. U.K. Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.7. U.K. Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.8. U.K. Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.9. France Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.10. France Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.11. France Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.12. France Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.13. Italy Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.14. Italy Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.15. Italy Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.16. Italy Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.17. Turkey Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.18. Turkey Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.19. Turkey Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.20. Turkey Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.21. Russia Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.22. Russia Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.23. Russia Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.24. Russia Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.25. Rest of Europe Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.26. Rest of Europe Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.27. Rest of Europe Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.1.28. Rest of Europe Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, 2018 - 2031
8.1. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Paclitaxel Drug Coating
8.1.1.2. Sirolimus drug Coating
8.1.1.3. Others
8.2. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Peripheral Arterial Disease
8.2.1.2. Peripheral Aneurysms
8.2.1.3. In-Stent Restenosis
8.2.1.4. Others
8.3. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Carotid Arteries
8.3.1.2. Fem-Pop Arteries
8.3.1.3. Iliac Arteries
8.3.1.4. Infrapop Arteries
8.4. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Ambulatory Surgical Centers/Outpatients
8.4.1.3. Cardiac Catheterization Labs
8.5. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. China Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.2. China Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.3. China Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.4. China Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.5. Japan Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.6. Japan Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.7. Japan Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.8. Japan Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.9. South Korea Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.10. South Korea Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.11. South Korea Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.12. South Korea Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.13. India Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.14. India Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.15. India Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.16. India Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.17. Southeast Asia Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.18. Southeast Asia Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.19. Southeast Asia Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.20. Southeast Asia Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.21. Rest of Asia Pacific Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.22. Rest of Asia Pacific Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.23. Rest of Asia Pacific Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.1.24. Rest of Asia Pacific Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Peripheral Drug Eluting Balloon Market Outlook, 2018 - 2031
9.1. Latin America Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Paclitaxel Drug Coating
9.1.1.2. Sirolimus drug Coating
9.1.1.3. Others
9.2. Latin America Peripheral Drug Eluting Balloon Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.2.1.1. Peripheral Arterial Disease
9.2.1.2. Peripheral Aneurysms
9.2.1.3. In-Stent Restenosis
9.2.1.4. Others
9.3. Latin America Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Carotid Arteries
9.3.1.2. Fem-Pop Arteries
9.3.1.3. Iliac Arteries
9.3.1.4. Infrapop Arteries
9.4. Latin America Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Ambulatory Surgical Centers/Outpatients
9.4.1.3. Cardiac Catheterization Labs
9.5. Latin America Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1. Key Highlights
9.5.1.1. Brazil Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.2. Brazil Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.3. Brazil Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.4. Brazil Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.5. Mexico Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.6. Mexico Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.7. Mexico Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.8. Mexico Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.9. Argentina Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.10. Argentina Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.11. Argentina Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.12. Argentina Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.13. Rest of Latin America Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.14. Rest of Latin America Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.15. Rest of Latin America Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.1.16. Rest of Latin America Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, 2018 - 2031
10.1. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Paclitaxel Drug Coating
10.1.1.2. Sirolimus drug Coating
10.1.1.3. Others
10.2. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. Peripheral Arterial Disease
10.2.1.2. Peripheral Aneurysms
10.2.1.3. In-Stent Restenosis
10.2.1.4. Others
10.3. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Carotid Arteries
10.3.1.2. Fem-Pop Arteries
10.3.1.3. Iliac Arteries
10.3.1.4. Infrapop Arteries
10.4. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Ambulatory Surgical Centers/Outpatients
10.4.1.3. Cardiac Catheterization Labs
10.5. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1. Key Highlights
10.5.1.1. GCC Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.2. GCC Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.3. GCC Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.4. GCC Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.5. South Africa Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.6. South Africa Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.7. South Africa Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.8. South Africa Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.9. Egypt Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.10. Egypt Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.11. Egypt Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.12. Egypt Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.13. Nigeria Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.14. Nigeria Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.15. Nigeria Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.16. Nigeria Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.17. Rest of Middle East & Africa Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.18. Rest of Middle East & Africa Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.19. Rest of Middle East & Africa Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.1.20. Rest of Middle East & Africa Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Product vs Indication Heatmap
11.2. Company Market Share Analysis, 2022
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Abbott Laboratories
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Boston Scientific Corporation
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Cook Medical Inc.
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. MicroPort Scientific Corporation (Endovastec™)
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Medtronic Plc.
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. Cardinal Health, Inc.
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. B. Braun Melsungen AG
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. BIOTRONIK SE & Co. KG
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Becton, Dickinson and Company
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. W. L. Gore & Associates Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Getinge AB
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Terumo Corp
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
11.4.13. Kyoto Medical Planning Co Ltd
11.4.13.1. Company Overview
11.4.13.2. Product Portfolio
11.4.13.3. Financial Overview
11.4.13.4. Business Strategies and Development
11.4.14. iVascular S.L.U
11.4.14.1. Company Overview
11.4.14.2. Product Portfolio
11.4.14.3. Financial Overview
11.4.14.4. Business Strategies and Development
11.4.15. AMG International GmbH
11.4.15.1. Company Overview
11.4.15.2. Product Portfolio
11.4.15.3. Financial Overview
11.4.15.4. Business Strategies and Development
11.4.16. ENDOCOR GmbH
11.4.16.1. Company Overview
11.4.16.2. Product Portfolio
11.4.16.3. Financial Overview
11.4.16.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec™)
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Drug-eluting Balloon Catheters Market Analysis & Forecast to 2023-2033: Market By Drug; By Indication; By End User; and By Region - Product Image

Global Drug-eluting Balloon Catheters Market Analysis & Forecast to 2023-2033: Market By Drug; By Indication; By End User; and By Region

  • Report
  • 145 Pages
  • Global
From
Global Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User - Forecast 2023-2030 - Product Image

Global Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User - Forecast 2023-2030

  • Report
  • 188 Pages
  • Global
From
Drug Eluting Balloons - Market Insights, Competitive Landscape, and Market Forecast - 2028 - Product Image

Drug Eluting Balloons - Market Insights, Competitive Landscape, and Market Forecast - 2028

  • Report
  • 150 Pages
  • Global
From
Drug Eluting Balloons Catheters Global Market Report 2024 - Product Image

Drug Eluting Balloons Catheters Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Drug Eluting Balloon Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Drug Eluting Balloon Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.